Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q5VTE6
UPID:
ANGE2_HUMAN
Alternative names:
-
Alternative UPACC:
Q5VTE6; B7Z2U4; D3DTA3; Q86X13; Q8NHH3
Background:
Protein angel homolog 2, identified by the accession number Q5VTE6, represents a significant entity in the proteomic landscape. Its unique structure and biochemical properties suggest a pivotal role in cellular processes. The exploration of its functions is at the forefront of current scientific inquiry, aiming to unravel the complexities of cellular mechanisms.
Therapeutic significance:
Understanding the role of Protein angel homolog 2 could open doors to potential therapeutic strategies. Its involvement in key biological pathways hints at its importance in maintaining cellular integrity and function. The identification of its precise role could lead to breakthroughs in targeted therapy, offering new avenues for disease management and treatment.